BOSTON and TEL AVIV, Israel, Sept. 17, 2025 /PRNewswire/ -- Mana.bio, a biotechnology company pioneering the intersection of artificial intelligence and RNA delivery, today announced the launch of Mina™, the world's first large language model (LLM) built specifically for lipid nanoparticles (LNPs). Mina - described as a "ChatGPT for LNPs" - is publicly available at no cost, marking a significant step forward in accelerating scientific discovery and advancing the future of gene therapy and RNA-based medicines.

"AI has transformed many industries, but biology is only beginning to realize its full potential," said Yogev Debi, co-founder and chief executive officer of Mana.bio. "At Mana, we've already achieved breakthroughs in RNA delivery by harnessing AI, showing how it can unlock entirely

See Full Page